Search
SOLACI Congress
HomeFileStructural heart disease

Structural heart disease

View Category

Structural heart disease

Severe Aortic Stenosis in Bicuspids: Promising Self-Expanding Valve Outcomes at 3 years

Bicuspid aortic valves represent a significant challenge in TAVR because of its anatomical complexity and the presence...
Dr. Carlos Fava -
Learn More
Other

Endovascular Management of Chronic TEPH: Is Coronary Management Extrapolatable in This Scenario?

Chronic thromboembolic pulmonary hypertension (CTEPH) is a condition that causes significant functional limitation. Its surgical treatment, known...
solaci -
Learn More
Structural heart disease

Myocardial Damage in MAC

Mitral annulus calcification (MAC) affects between 8% and 23% of the population. It is more common in...
solaci -
Learn More
Structural heart disease

Edge-to-Edge Repair for Right Ventricular Function Deterioration

Tricuspid regurgitation (TR) has been associated with worse survival and hospitalization for cardiac failure (CF). The current...
solaci -
Learn More
Structural heart disease

Evolution of Cardiac Damage in MitraClip

Degenerative mitral valve regurgitation affects the mitral apparatus and is related to severe insufficiency. At present, surgery...
solaci -
Learn More
Structural heart disease

Cardioband in Tricuspid Valve Regurgitation

Untreated tricuspid regurgitation (TR) has been associated to high morbimortality. Surgical treatment of isolated severe TR is...
solaci -
Learn More
Structural heart disease

2 Year Outcomes of Transcatheter Mitral Valve Replacement with Intrepid

Severe mitral valve insufficiency (MI) has been associated to the progressive deterioration of left ventricular function, cardiac...
solaci -
Learn More
Coronary disease

QFR Analysis of Coronary Lesions with TAVR

While transcatheter aortic valve replacement (TAVR) has shown benefits, significant coronary artery disease affects 50% or more...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Dr. Omar Tupayachi - 0
Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Dr. Juan Manuel Pérez - 0
Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....

TAVR in Pure Native Aortic Regurgitation: Are Dedicated Devices Truly Superior?

Dr. Juan Manuel Pérez - 0
This systematic meta-analysis assessed the efficacy and safety of transcatheter aortic valve replacement (TAVR) in patients with pure native aortic regurgitation. The emergence of...

Institutional News

SOLACI Wishes You Happy Holidays

solaci - 0
From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

solaci - 0
The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy